Trials / Completed
CompletedNCT02601235
Efficacy and Safety of Pediatric Drugs in Nasal Congestion
Clinical Evaluation of Safety and Efficacy of Pediatric Naridrin in Comparison to Afrin on the Improval of Nasal Congestion.
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 292 (actual)
- Sponsor
- EMS · Industry
- Sex
- All
- Age
- 10 Years – 17 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the efficacy of the Naridrin in improving nasal congestion.
Detailed description
Open label, randomized, multicenter clinical study. Maximal experiment duration: 2 days; 2 visits. Safety and efficacy evaluation
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Naridrin | Naridrin® : 2 drops in each nostril once daily as prescription |
| DRUG | Afrin | 2 pumps in each nostril every 12 hours. |
Timeline
- Start date
- 2018-01-16
- Primary completion
- 2018-08-03
- Completion
- 2019-04-03
- First posted
- 2015-11-10
- Last updated
- 2019-10-16
Locations
1 site across 1 country: Brazil
Source: ClinicalTrials.gov record NCT02601235. Inclusion in this directory is not an endorsement.